Your browser is out-of-date.

Please, update your browser to view this website correctly. Update my browser now

×

37th Vicenza Course on AKI &CRRT

Room: Giotto - AKI Path

SESSION 2 | UVA - IRRIV session: AKI in Transplant & Cancer

Chairmen: 

M. Rosner | F. Fabris

 

08.10

AKI in the Late Post-Transplant Period

 

A. Doyle

08.30

AKI in the Early Post-Transplant Period    

 

K. Warburton

08.50

AKI in the Cancer Patient

 

M. Rosner

09.10

Peritoneal Dialysis in the Patient with AKI

 

S. Khan

09.30

Discussion

 

09.40

Break

 

SESSION 3 | KDIGO-IRRIV Session: KDIGO Guidelines and Controversies

Chairmen: 

L. Forni | J. Kellum

10.00

What’s changed since the last KDIGO AKI guideline?

 

M. Ostermann

10.15

Diagnostic and nomenclature controversies

 

K. Kashani

10.30

Fluids and drugs

 

J. Prowle

10.45

RRT Controversies

 

R. Bellomo

11.00

What’s next?

 

J. Kellum

11.20

Discussion

 

Industry-Sponsored Symposium

13.00

Lunch

 

SESSION 4 | ADQI - IRRIV session: Quality Measures and Prevention in AKI

Chairmen: 

A. Pani | K. Kashani

15.00

Quality Standards to prevent AKI

 

A. Lewington

15.20

AKI risk modification quality indexes

 

A. Zarbock

15.40

Quality of care and safety measures after AKI

 

K. Kashani

16.00

Quality of care and safety for Acute Kidney Disease

 

J. Koyner

16.20

Discussion

 

16.30

Break

 

SESSION 5 | AKI Biomarkers

Chairmen: 

M. Plebani | T. Rimmelé

17.00

FAQs on AKI biomarkers

J. Kellum

17.20

AKI Biomarkers in cardiac patients

 

P. A. McCullough

17.40

Biomarker-driven preventive actions

 

A. Zarbock

18.00

How do I use AKI biomarkers

L. Forni

18.20

Discussion

 

18.30

Adjourn

 

Room: Tiziano - CRRT Path

SESSION 2 | Clinical Aspects of CRRT

Chairmen: 

S. Bagshaw | V. Cantaluppi

 

08.10

When and how I prescribe CRRT

 

R. L. Mehta

08.30

Initiation and discontinuation of CRRT

 

S. Bagshaw

08.50

Quality indicators in CRRT

 

C. Ronco

09.10

Clotting or bleeding what is worse?

 

R. Bellomo

09.30

Discussion

 

09.40

Break

 

SESSION 3 | Practical Management of CRRT

Chairmen: 

S. De Rosa | G. Villa

10.00

CRRT: what are the unsolved issues?

 

S. Bagshaw

10.20

Acid Base and Electrolyte correction

 

P. Honoré

10.40

Choice of CRRT modality

 

S. Romagnoli

11.00

Convection or diffusion? The evidence

 

Z. Ricci

11.20

Discussion

 

Industry-Sponsored Symposium

13.00

Lunch

 

SESSION 4 | CCH - IRRIV session: Pediatric AKI

Chairmen: 

S. Goldstein | E. Vidal

15.00

Pediatric AKI: Epidemiology and Outcomes

 

S. Sutherland

15.20

AKI in Neonates: Epidemiology and Outcomes

 

D. J. Askenazi

15.40

Acute RRT in the Pediatric Setting

 

Z. Ricci

16.00

Moving Forward with AKI Treatment in Children: Risk Stratification and Biomarker Integration to Direct Care

S. Goldstein

16.20

Discussion

16.30

Break

 

SESSION 5 | CCCN - IRRIV session: Kidney Frailty

Chairmen: 

R. Murugan | V. Cantaluppi

17.00

Detecting the frail kidney with RFR

 

F. Husain-Syed

17.20

Kids have frail kidneys too

D. Fuhrman 

17.40

Managing the frail kidney with CRRT

 

R. Murugan

18.00

Cellular mechanism of kidney frailty 

 

D. Emlet

18.20

Discussion

 

18.30

Adjourn

 

Room: Canova

Meet the Experts Path

10.00

When and How to prescribe RRT in AKI

 

R. L. Mehta-A. Zarbock

10.45

Diagnosing and managing aHUS and kidney complications

 

F. Fabris-D. J. Askenazi

13.00

Lunch

 

15.00

How to manage fluids in AKI and RRT

 

R. Bellomo-M. Ostermann

15.45

Managing anticoagulation in CRRT

 

A. Tolwani-G. Villa